Clinical Trial: Off-Label Treatment With Immune Checkpoint Inhibitor Blockade

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754292) titled 'Off-Label Treatment With Immune Checkpoint Inhibitor Blockade' on Aug. 04.

Brief Summary: This is a phase II therapeutic interventional clinical trial that will evaluate the efficacy, safety, and outcomes of off-label immune checkpoint blockade use across malignancies.

Study Start Date: Nov. 01, 2026

Study Type: INTERVENTIONAL

Condition: Malignancy

Intervention: DRUG: One or more off-label ICIs alone or with other on-label ICI(s)

Subjects will receive one of three ICI regimens, as prescribed by their treating medical oncologist.

DRUG: Off-label ICI(s) with targeted therapy

Subjects will receive one of three ICI regimens, as...